HAE
Haemonetics Corp
$85.43
Earnings Summary
Revenue | $345.51Mn |
Net Profits | $33.83Mn |
Net Profit Margins | 9.79% |
Highlights
Haemonetics Corp’s revenue jumped 8.59% since last year same period to $345.51Mn in the Q3 2024. On a quarterly growth basis, Haemonetics Corp has generated 2.78% jump in its revenue since last 3-months.
Haemonetics Corp’s net profit jumped 35.82% since last year same period to $33.83Mn in the Q3 2024. On a quarterly growth basis, Haemonetics Corp has generated -11.84% fall in its net profits since last 3-months.
Haemonetics Corp’s net profit margin jumped 25.08% since last year same period to 9.79% in the Q3 2024. On a quarterly growth basis, Haemonetics Corp has generated -14.22% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Haemonetics Corp post its latest quarter earnings
EPS Estimate Current Quarter | 1.07 |
EPS Estimate Current Year | 1.07 |
Highlights
Haemonetics Corp’s earning per share (EPS) estimates for the current quarter stand at 1.07 - a 5.94% jump from last quarter’s estimates.
Haemonetics Corp’s earning per share (EPS) estimates for the current year stand at 1.07.
Key Ratios
Key ratios of the Haemonetics Corp post its Q3 2024 earnings
Earning Per Share (EPS) | 1.12 |
Highlights
Haemonetics Corp’s earning per share (EPS) jumped 13.13% since last year same period to 1.12 in the Q3 2024. This indicates that the Haemonetics Corp has generated 13.13% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-08 | 1.01 | 1.02 | 0.99% |
2024-11-07 | 1.07 | 1.12 | 4.67% |
2024-05-20 | 0.89 | 0.9 | 1.12% |
₹0 US Stocks a/c Opening Fee